feed,title,long_url,short_url
Benzinga,"Histogen Stops HST 001 Development After Trial Failure, Shifts Focus On Programs For Orthopedic Indications",https://benzinga.com/general/biotech/21/06/21409754/histogen-stops-hst-001-development-after-trial-failure-shifts-focus-on-programs-for-orthopedic-in,https://j.mp/3wVvOKs
